Background: Subacromial impingement syndrome (SAIS) is the most common cause of shoulder pain and is costly, in terms of disability and health service provision.
| INTRODUCTION
Shoulder pain is a common and often persistent musculoskeletal problem (Diercks et al., 2014; Roquelaure et al., 2006; van der Heijden, 1999) . In the UK, the incidence of shoulder pain is very common and one in three people will suffer from shoulder pain at some point (Linsell et al., 2006; van der Heijden, 1999) . Shoulder pain is often associated with difficulties in performing functional activities, such as getting dressed (Linsell et al., 2006) and throwing a ball (Seroyer et al., 2009) , and impairs the ability to sleep (Kromer, Tautenhahn, de Bie, Staal, & Bastiaenen, 2009) , hence affecting mood and concentration (Green, Buchbinder, & Hetrick, 2003) . Of all the disorders causing shoulder pain, subacromial impingement syndrome (SAIS) is the most common. Linsell et al. (2006) found that during a 3-year follow-up period of patients consulting for shoulder disorders in UK primary care, 22.4% of them were referred to secondary care, 30.8% were prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) and 10.6% were given a cortisone injection by their general practitioner (GP).
Using figures from a comprehensive evaluation of shoulder disorders, Arthritis Research UK has estimated the cost of shoulder pain in the general population to be in the region of £100 million (Garg, Prince, & Cole, 2010) . Although the cost of cortisone injections, physiotherapy and surgery for SAIS varies widely, physiotherapy and surgery have each been reported to cost more when compared with cortisone injections (James, Stokes, Thomas, Dziedzic, & Hay, 2005; Ketola et al., 2009 ).
Subacromial injection is the recommended treatment for patients with SAIS, particularly when physiotherapy has failed or the pain is limiting exercise (Diercks et al., 2014; Hanchard, Cummins, & Jeffries, 2004; Lewis, 2011) . A recent systematic review and meta-analysis of randomized controlled trials (RCTs) showed that cortisone injections provide moderate pain relief for patients with rotator cuff disorders up to 2 months after the injection (Mohamadi, Chan, Claessen, Ring, & Chen, 2016) , but the benefit was not sustained after this time. Previous systematic reviews that investigated the effectiveness of cortisone injections in the treatment of shoulder pain (Arrol & Goodyear-Smith, 2005; Buchbinder, Green, & Youd, 2003; Johansson, Oberg, Adolfsson, & Foldevi, 2002) reported varying methodological quality and a heterogeneity of populations, and argued that sample sizes were generally small. However, their conclusions were nevertheless similar: subacromial cortisone injection is effective in the management of SAIS and more effective when compared with placebo, acupuncture, ice, heat and exercise. The findings of those reviews were consistent with the recommendations of the National Institute for Health and Care Excellence (NICE) (National Institute for Health and Care Excellence, 2015) , and the results of a systematic review that was commissioned by the Chartered Society of Physiotherapy (Hanchard et al., 2004 ) and a recent Dutch review (Diercks et al., 2014) , all of which recommends that cortisone injection should be provided to patients with SAIS.
Anterior, posterior and lateral approaches for subacromial injections are described in the literature (Marder, Kim, Labson, & Hunter, 2012; Sardelli & Burks, 2008; Saunders, 2010; Saunders & Longworth, 2012) , with the latter two most commonly used (Saunders, 2010) . Although the choice of needle placement is based on preference, experience or anatomy, the evidence establishing the superiority of one method over the other in normal practice is not only scarce, but also still controversial. The purpose of the present systematic review was to compare these needle placements for subacromial injection, to establish which is more effective for patients with SAIS.
2 | METHODS 2.1 | Data source and search strategy A literature search of CINAHL, MEDLINE, PEDro and E-Journal databases using full texts, from 1980 to April 2014 and updated in December 2016, was conducted using the "MESH" headings and keywords "shoulder pain", "shoulder impingement syndrome", "subacromial impingement syndrome", "shoulder", "subacromial", "supraspinatus", "rotator cuff", "bursitis", "impinge", "tendonitis", "tendinitis", "pain" and "pathology" in combination with "cortisone injection"
or "hydrocortisone injection" or "triamcinolone acetonide injection" or "Kenalog injection", and "clinical trials", "case studies" and "systematic reviews". With the exception of PEDro, the Chartered Society of Physiotherapy EBSCOhost electronic databases was used to search all the databases (see Table 1 ). This was supplemented by searching reference lists of articles identified in the electronic searches, including previous systematic reviews, grey literature, contacting experts via email and verbal communication, as well as manual searches of books.
| Study design
The inclusion criteria, in terms of study design, were randomized controlled trials and nonrandomized controlled trials, limited to human subjects and published in the English language. Non-English language studies were not included because of the costs and delays incurred by translating into the English language.
| Study participants
The inclusion criteria for participants were that they were ≥18 years of age, with a diagnosis of SAIS. Studies in which participants presented with spinal or shoulder surgery (in the past 6 months), current spinal or upper limb fracture, previous hydrocortisone injection in the past 4 weeks, shoulder dislocation/instability, current frozen shoulder, acromioclavicular joint arthritis, os acromiale or bony metastases were excluded.
| Study interventions
Participants had to have received a cortisone injection, by the anterior, posterior or lateral approach, for the management of SAIS. Studies where participants were allowed to continue with their usual treatment, such as pain medication or physiotherapy, were included in the review. 
| Study outcomes

| Assessment of trial quality
Prior to commencing the review, it was determined that the quality of any RCTs identified would be assessed using the PEDro scale (http:// www.pedro.fhs.usyd.edu.au). Each included publication was scored by the reviewer (C.O.), using the scale consisting of 10 checklists. As the present systematic review was undertaken by the reviewer as part of a doctorate degree programme, the data extracted were then reviewed by both the reviewer (C.O.) and his academic supervisor (S.B.). Any discrepancies in this process were resolved by discussion between the two. Each checklist was allocated one point, with 10 as the maximum (indicating highest quality) and 0 as the minimum (indicating lowest quality).
3 | RESULTS
| Trials included in the review
The search of the databases identified a total of 4,265 citations from the electronic databases, and an additional 25 papers were also found from the reference lists and grey literature; of the total number of papers retrieved, 1,249 were duplicates and 3,002 were rejected following a review of the abstracts. Of the 39 potentially eligible studies, 31 were excluded (29 did not have an intervention of interest and the remaining two were commentaries), leaving eight articles that were possibly relevant to the present study (see Figure 1 for details).
| Population characteristics
In total, 363 patients (217 women, 146 men), with a mean age ranging from 34 to 78 years (youngest 18, oldest 80), were included in the eight trials reviewed. Within the trials, participant numbers ranged from 30 (Sardelli & Burks, 2008) to 75 (Marder et al., 2012) . The follow-up periods in the trials ranged from 15 min (Yamakado, 2002) to 3 months (Marder et al., 2012) post-injection. One study (Sardelli & Burks, 2008) had no follow-up. The study information, design, intervention, follow-up and summary of findings, together with the study's limitations, are detailed in (Table 2), Table 3 .
| Study design
We found three non-RCTs (Esenyel et al., 2003; Eustace, Brophy, Gibney, Bresnihan, FitzGerald, 1997; Yamakado, 2002) S20 S15 OR S16 OR S17 OR S18 3,814,037 S21 S10 AND S15 AND S20 4,265
Rizio, Prybicien, Middlemas, & Blacksin, 2008; Marder et al., 2012) and one non-RCT (Sardelli & Burks, 2008 ) directly evaluated the effects of different approaches for cortisone injection in SAIS treatment.
| Trial quality
We found three non-RCTs (Esenyel et al., 2003; Eustace et al., 1997; Yamakado, 2002) that directly evaluated the effect of one approach for cortisone injection in the treatment of SAIS. Four RCTs (Goel et al., 2012; Henkus et al., 2006; Kang et al., 2008; Marder et al., 2012) and one non-RCT (Sardelli & Burks, 2008 ) directly evaluated the effects of different approaches for cortisone injection the SAIS treatment of this condition. These four RCTs had adequate concealment allocation in the randomization process. In six studies (Goel et al., 2012; Henkus et al., 2006; Kang et al., 2008; Marder et al., 2012 Kang et al., 2008) there was adequate follow-up and in the other four there was not. In none of the studies were participants or therapists blinded. An intent-to-treat analysis was performed in two trials (Henkus et al., 2006; Kang et al., 2008) , but in six it was not. Table 2 details the methodological quality of the studies included in the present review.
| Outcomes included in the studies
The outcomes used in the identified studies included: a visual analogue scale (VAS) in five trials (Esenyel et al., 2003; Eustace et al., 1997; Goel et al., 2012; Henkus et al., 2006; Marder et al., 2012) ;
the Constant-Murley score (Goel et al., 2012) in three trials (Esenyel et al., 2003; Goel et al., 2012; Henkus et al., 2006) ; a five-point global rating scale in one trial (Eustace et al., 1997 ); a four-point selfadministered pain scale in one trial (Yamakado, 2002 Marder et al., 2012; Yamakado, 2002) ; the University of California at Los Angeles shoulder score in one trial (Kang et al., 2008) ; the accuracy of the injection into the bursa in one trial (Sardelli & Burks, 2008) ; and in one trial (Yamakado, 2002 ) the needle distance to the subacromial space using the lateral, anterior and posterior routes, and pain expressed as Neer and Hawkins impingement signs were obtained before and 15 min after the injection.
| EFFECTS OF INTERVENTION
| Accurately placed versus nontarget subacromial injections
Three non-RCT trials (Esenyel et al., 2003; Eustace et al., 1997; Yamakado, 2002) compared accurately placed injections with nontarget injections into the subacromial space. In these trials, injection accuracy was defined as those injections that were correctly placed within the subacromial space, whereas injection accuracy was measured by needle placement into the subacromial space. The three studies reported a significant benefit of accurately placed injections into the subacromial space compared with those outside this space. Eustace et al. (1997) found that 14 of the 38 procedures (37%) were judged to be accurately placed: four of the 14 attempted subacromial injections (29%) and 10 of the 24 attempted glenohumeral injections (42%). There were significant differences in relation to outcome between the accurately placed and the inaccurately placed groups. Esenyel et al. (2003) reported that the injections were placed accurately in 42 patients (87%), whereas in six patients (12.5%) delivery to the target site failed; however, both groups showed significant improvements 30 min after the injections (p < 0.05). Only the injections that were accurately placed showed significant improvement after 2 weeks. Goel et al. (2012) reported that injections for SAIS were accurately placed in 22 patients (78.5%) using the posterior approach, and in 14 patients (63.6%) using the anterolateral approach; this difference was significant (p < 0.05). Only patients who received the injection accurately, using either method, had a reduction in pain of, on average, 4 points on the VAS, and an improvement in the Constant-Murley score of, on average, 14 points.
| Posterior versus anterolateral approach to subacromial injection
One RCT (Goel et al., 2012) Goel et al 2012 Within 24 hours and 6 weeks after infiltration 13 injections (76%) were in the subacromial bursa with a posterior approach and 10 (69%) with an anteromedial approach. A positive correlation between the injection confidence of the orthopaedic surgeon and the MRI was found in 66%. Only injection of the subacromial bursa alone resulted in a significant decrease of the pain (P = .004) and an increase in the functional scores. Injection in the bursa and rotator cuff muscle showed a significant increase in The weakness of this study includes the short follow-up period and small sample size.
(Continues) were assessed by the UCLA shoulder score and a 10-point
VAS pain
During the initial, postinjection, and 3-month visits. Overall accuracy was 70%, with no difference among the 3 portals. Accuracy was not related to BMI.
Also, accurate injections did not significantly improve the UCLA score, pain scale, or patient satisfaction at 3 months. In contrast, accurate injections produced a positive Neer's impingement test more often (35/ 39 vs 9/16; P = .009). Overall, there was an improvement in the UCLA score (26.2-32.2; P < .001) and a decrease in the pain scale (7.2-3.43; P < .001) at 3-month follow-up. In conclusion, the accuracy of injection was 70% The use of composite interventions of NSAIDs, physical therapy and cortisone injection/local anaesthetic on each patient makes it was difficult to single out the contributions of the additional effects of cortisone injection alone. This was an accuracy study therefore it does not demonstrate efficacy of (Continues) route and 92% for the lateral route (p = 0.006; chi-square test). The accuracy through the posterior route was significantly lower than that through the anterior or lateral route (p < 0.05 for both comparisons;
Study
Poisson regression). The accuracy of injection was significantly lower in women than in men (p < 0.006; chi-square test). Among males, no differences between the routes were noted (with an accuracy of 89% for the posterior route, 92% for the anterior route and 93% for the lateral route). Among women, the accuracy was lower for the posterior route than for either the anterior or the lateral route (38% for the posterior route, 77% for the anterior route and 91% for the lateral route) (p < 0.05).
4.5 | Posterior, anterior versus lateral approach of needle length distance to the subacromial space
One non-RCT trial (Sardelli & Burks, 2008) compared the needle distance to the subacromial space using the lateral, anterior and posterior routes. It reported that the mean distances were 2.9 ± 0.6 cm using the anterior route, 2.9 ± 0.7 cm using the lateral route and 5.2 ± 1.1 cm using the posterior route.
| DISCUSSION
Cortisone injection is common in the treatment of shoulder pain due to SAIS (National Institute for Health and Care Excellence, 2015, Ellegaard et al., 2016) . Although some studies (Goupille & Sibilia, 1996; van der Heijden, van der Windt, Kleijnen, Koes, & Bouter, 1996) on the efficacy of subacromial corticosteroid injections were inconclusive, several authors have subsequently confirmed its effectiveness and recommended its use for SAIS (Diercks et al., 2014; Dorrestijn, Stevens, Winters, van der Meer, & Diercks, 2009 , Hanchard et al., 2004 National Institute for Health and Care Excellence, 2015) . Subacromial injections can be performed using the anterior (front), lateral (side) and posterior (back) approaches (Bloom, Rischin, Johnston, & Buchbinder, 2012; Marder et al., 2012; Sardelli & Burks, 2008; Saunders, 2010; Saunders & Longworth, 2012) . It has been reported that some practitioners support either a lateral (Saunders, 2010) or a posterior (Marder et al., 2012; Saunders & Longworth, 2012) approach to the subacromial injection.
Several studies, both cadaveric and clinical, investigating needle placement in subacromial injections have had mixed results, using a multiple or single injection approach. Four studies (Henkus et al., 2006; Kang et al., 2008; Marder et al., 2012; Sardelli & Burks, 2008) investigated needle placement into the subacromial space in patients with SAIS. They assessed the accuracy of the anterior, lateral and posterior approaches by using magnetic resonance imaging (Henkus et al., 2006) , radiographic contrast dye (Kang et al., 2008) , arthroscopy (Sardelli & Burks, 2008) or radiopaque contrast (Marder et al., 2012) as a reference. Although the injections were performed by experienced clinicians, they were done with the aid of a diagnostic evaluation; however, in normal practice, clinicians such as extended scope physiotherapists and GPs do not routinely use imaging guidance when injecting into the shoulder. In all four studies, a single orthopaedic were seen to have entered the deltoid muscle; 2 (4%) were in the glenohumeral joint; and 3 (5%)
were subcutaneous. A comparison of subacromial bursal with intradeltoid injection showed no significant differences in pain reduction expressed as impingement signs (1.5 vs 1.7 in the Neer impingement sign and 1.6 vs 1.6 in the Hawkins impingement sign, respectively). The weakness of this study includes the short follow-up period which is not applicable in normal clinical practice where injection followup periods are much longer surgeon performed all the injections. The lack of measures of interrater agreement in these studies could have compromised their intra-rater reliability.
The results of two of the studies (Henkus et al., 2006; Kang et al., 2008) showed that the anterior, lateral and posterior approaches had no advantage over each other. By contrast, the study by Goel et al.
(2012) favoured a posterior approach (with an accuracy of 78.5%) compared with the anterolateral route (with an accuracy of 63.6%).
Although the study used concealed random allocation, and the treating consultant or registrar was blinded to the results of injection accuracy, the use of a single experienced clinician to review the images might have introduced experiment or treatment bias, limiting intra-rater reliability. The finding of the latter study is in contrast to the results of some previous authors (Esenyel et al., 2003; Partington, & Broome, 1998; Yamakado, 2002) Furthermore, Marder et al. (2012) demonstrated that subacromial injection using anterior and lateral routes was more accurate in women than the posterior route. These authors showed that sample size was adequately powered, based on sample calculations from previous studies (Kang et al., 2008; Yamakado, 2002) .
However, in the study by Marder et al. (2012) , post-injection outcomes for accuracy and level of pain were measured at 10 min and between 30 min and 1 h, respectively, by a radiologist. This follow-up regime is in contrast to normal musculoskeletal or GP clinical practice, where follow-up periods are much longer (4-12 weeks). Sardelli and Burks (2008) recommended that, as the accuracy was lowest when using the posterior, compared with lateral and anterior, approach, a longer needle is necessary when using it, to improve the success of the procedure. The question, therefore, is why clinicians traditionally adopt the posterior approach if it has the least accuracy.
The uncertainty regarding which subacromial injection approach is superior is exacerbated by the varying methodological quality, clinical and statistical heterogeneity of the individual studies included in the present review. Owing to these variations, it was not possible to pool data for a meta-analysis. Furthermore, the uncertainty of any conclusion reached was exacerbated by the fact that the individual studies used different types of corticosteroid, so it was difficult to comment on whether an improvement was related to the type of corticosteroid used or the placement of the needle.
| CONCLUSION
Critical evaluation of studies on the posterior, anterior and lateral approaches to subacromial injections found no consensus in the evidence to establish the superiority of any one method of injection approach over the other in clinical practice. Further, well-designed, randomized controlled trials are required to determine the effectiveness of the lateral, anterior versus posterior approach to subacromial injection in adults with SAIS.
